Jobs
View more job listings or post a job
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
AMOGH PHARMA HEALTH PULSE SUITABLE
AMOGH PHARMA HEALTH PULSE SUITABLE
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
Post a job
Webcast

For PBSS members outside Vancouver [Webcast from PBSS Vancouver] Antibody Engineering for ADCs


Speakers: Bernhard Geierstanger, PhD, Co-founder and Chief Technology Officer, Firefly Bio
Organizers: PBSS Vancouver
Date: 2024-09-11
Time: 10:00-12:30 Pacific Time
Registration fee: Attendees, CDN$10; Vendors: CDN$350; Major Sponsor: CDN$1500
Location: Webcast from PBSS Vancouver.
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-09-10  (it will close sooner if the seating cap is reached)


About the Speakers

Bernhard Geierstanger is CTO and co-founder of FireflyBio, a bay area ADC startup. He is an expert in protein engineering, ADCs and biotherapeutics. Before FireflyBio, he worked at Merck (MRL) and the Genomics Institute of the Novartis Research Foundation (GNF) leading teams that develop innovative biotherapeutics. Several of these have advanced to clinical trials. He has also pioneered novel methods for protein modification, site-specific conjugation, and the use of immune stimulating ADC payloads.

Bernhard holds a Ph.D. in Biophysics from UC Berkeley and was a postdoctoral fellow at Stanford University. He has authored >60 publications and is an inventor on >30 patents and patent applications.

Other Events of PBSS-Vancouver:

2024-10-22, [In-Person] Translational Pharmacology Models in Drug Development: Fundamentals, Applications, and Case Studies Related to Oncology, Metabolic Diseases, CNS, and Immunology
2024-10-22, [Webcast from PBSS Vancouver for PBSS members outside Vancouver only] Translational Pharmacology Models in Drug Development: Fundamentals, Applications, and Case Studies Related to Oncology, Metabolic Diseases, CNS, and Immunology
©Pharmaceutical & BioScience Society, International; Last Modified: 10/21/2024; Admin Logon
 Ads (in random order)
Submit a Text Ad
($250 for 2 months)
PharmaResources Top-tier small molecule CRO/CDMO offering comprehensive supports from Medicinal Chemistry, DMPK, and CMC to GMP manufacturing for commercialization.
Aroga Biosciences Aroga Biosciences is an award-winning CRO specializing in scientific writing for nonclinical reports, INDs, CMC, and clinical documents.
Allucent Bringing innovation to Biotech w/ClinPharm Modeling & Simulation services to inform dose, design, modeling + development strategies.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad